Navigating Clinical Likelihood and Cardiovascular Risk over a Lifetime Course of Coronary Artery Disease

European Journal of Preventive Cardiology · Published 2026-07-21 · DOI 10.1093/eurjpc/zwag380

Authors (3)

Simon Winther, Laust D Rasmussen, Christiaan J M Vrints

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Winther, S., Rasmussen, L., Vrints, C. (2026). Navigating Clinical Likelihood and Cardiovascular Risk over a Lifetime Course of Coronary Artery Disease. European Journal of Preventive Cardiology. https://doi.org/10.1093/eurjpc/zwag380

Related articles

• The role of lipoprotein (a) in premature cardiovascular disease: primed for prevention · European Journal of Preventive Cardiology · 2026 · Same journal
• Interplay of HDL cholesterol and apoB and the risk of incident atherosclerotic cardiovascular disease in UK Biobank · European Journal of Preventive Cardiology · 2026 · Same journal
• Rheumatoid arthritis and risk of myocardial infarction: A nationwide cohort study · European Journal of Preventive Cardiology · 2026 · Same journal
• Beyond Survival: The Eriksen Case and the Dilemma of Elite Sport Participation After Sudden Cardiac Arrest · European Journal of Preventive Cardiology · 2026 · Same journal
• Cardiovascular prevention in childhood and young adults · European Journal of Preventive Cardiology · 2026 · Same journal
• Rethinking how we characterize the exercise blood pressure response in athletes · European Journal of Preventive Cardiology · 2026 · Same journal
• Baseline Anemia and Short Dual Antiplatelet Therapy in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention · European Journal of Preventive Cardiology · 2026 · Same journal
• Safe hearts need a healthy environment: prevention beyond our clinic walls · European Journal of Preventive Cardiology · 2026 · Same journal
• Multidisciplinary cardiac rehabilitation—an indispensable therapeutic intervention when starting a GLP-1 receptor agonist therapy? · European Journal of Preventive Cardiology · 2026 · Same journal
• Pharmacological risk stratification of Lp(a): diabetes status may refine residual cardiovascular risk beyond ASCVD history · European Journal of Preventive Cardiology · 2026 · Same journal